The largest database of trusted experimental protocols

Tyrphostin ag1024

Manufactured by Merck Group

Tyrphostin AG1024 is a tyrosine kinase inhibitor. It functions by selectively inhibiting the activity of the insulin-like growth factor 1 receptor (IGF-1R) and the epidermal growth factor receptor (EGFR).

Automatically generated - may contain errors

2 protocols using tyrphostin ag1024

1

IGF1 Signaling Pathways Modulation

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells were serum-starved for 24 hr, after which they were treated with 50 ng/ml of IGF1 (PeproTech Ltd., Rocky Hill, NJ) and/or 300 micromolar of dansylcadaverine (Sigma-Aldrich) for different time periods. In addition, cells were treated with the following specific IGF1R inhibitors: tyrosine kinase inhibitor NVP-AEW541 (2 micromolar) (Novartis) or tyrphostin AG1024 (1 micromolar) (Sigma-Aldrich).
+ Open protocol
+ Expand
2

Inhibiting IGF-1 and Hedgehog Pathways

Check if the same lab product or an alternative is used in the 5 most similar protocols
Some mice (N=3) were administered the IGF-1 inhibitor Tyrphostin AG1024 (Sigma) daily beginning on the day of hydrogel implantation for 21 days. AG1024 (30µg) was delivered in DMSO (3µL) (Sigma) and PBS (200µL) via an IP injection. Vehicle group received DMSO in PBS via an IP injection daily for 21 days. Other mice (N = 3) were administered 10mg/kg/day of Sonidegib (0.25mg; Selleck Chemicals) in 2% DMSO (Sigma) and corn oil (Sigma) for 21 days for the treatment group or 2% DMSO in corn oil for vehicle group via an IP injection. The first dose was administered on the day of hydrogel implantation and continued daily for 21 days. Hydrogels and surrounding tissues were excised and RNA was isolated.
Samples were then assayed for gene expression via RT-qPCR.
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!